These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22907238)

  • 21. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
    Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P
    J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
    Santamato A; Ranieri M; Solfrizzi V; Lozupone M; Vecchio M; Daniele A; Greco A; Seripa D; Logroscino G; Panza F
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):843-6. PubMed ID: 27291256
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
    Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity.
    Varghese-Kroll E; Elovic EP
    Am J Phys Med Rehabil; 2009 Jun; 88(6):495-9. PubMed ID: 19454855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC; Bowen B; Liu J; Brin MF
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper Limb Motor Function Affects the Outcome after Treatment with Botulinum Toxin A.
    Fujimura K; Kagaya H; Onaka H; Nagasawa N; Ishihara A; Okochi Y; Yamada M; Tanikawa H; Kanada Y; Saitoh E
    Eur Neurol; 2019; 81(1-2):30-36. PubMed ID: 31013501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J; Rubin JM; Chen J; O'Dell M
    Ultrasound Med Biol; 2019 May; 45(5):1094-1102. PubMed ID: 30898386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A; Mayer NH; Elia AE; Albanese A
    Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
    Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
    NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatosensory evoked potentials of hand muscles in stroke and their modification by botulinum toxin: a preliminary study.
    Basaran A; Emre U; Karadavut KI; Bulmus N
    J Rehabil Med; 2012 Jun; 44(7):541-6. PubMed ID: 22674234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
    Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The features of botulinum therapy for different patterns of poststroke spasticity].
    Krylova LV; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):42-48. PubMed ID: 28374692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.